| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | gated channel activity | 1.72e-07 | 334 | 26 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | channel activity | 2.23e-07 | 525 | 26 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 2.26e-07 | 526 | 26 | 8 | GO:0022803 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.46e-06 | 459 | 26 | 7 | GO:0005216 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1D SLC35E3 KCNH7 PIEZO2 TRPA1 TMC5 RHBDF2 KCNH1 RHCE CFTR | 2.48e-06 | 1289 | 26 | 10 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 1.07e-05 | 1180 | 26 | 9 | GO:0022857 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 4.23e-05 | 152 | 26 | 4 | GO:0022843 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 5.15e-05 | 793 | 26 | 7 | GO:0015075 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 7.10e-05 | 343 | 26 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 8.53e-05 | 182 | 26 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 8.90e-05 | 184 | 26 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 2.46e-04 | 18 | 26 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 3.52e-04 | 758 | 26 | 6 | GO:0015318 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 8.40e-04 | 33 | 26 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.14e-03 | 627 | 26 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.47e-03 | 664 | 26 | 5 | GO:0008324 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.63e-03 | 46 | 26 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.96e-03 | 193 | 26 | 3 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.08e-03 | 197 | 26 | 3 | GO:0022834 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.89e-03 | 465 | 26 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | peptidase activator activity | 3.73e-03 | 70 | 26 | 2 | GO:0016504 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 7.75e-03 | 102 | 26 | 2 | GO:0005249 | |
| GeneOntologyMolecularFunction | peptidase activity | 9.61e-03 | 654 | 26 | 4 | GO:0008233 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.06e-02 | 120 | 26 | 2 | GO:0004222 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.11e-02 | 123 | 26 | 2 | GO:0030165 | |
| GeneOntologyMolecularFunction | potassium channel activity | 1.20e-02 | 128 | 26 | 2 | GO:0005267 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.22e-02 | 129 | 26 | 2 | GO:0005262 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 4.35e-06 | 559 | 26 | 7 | GO:0042391 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic anion transport | 9.15e-06 | 4 | 26 | 2 | GO:1903793 | |
| GeneOntologyBiologicalProcess | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 3.56e-05 | 51 | 26 | 3 | GO:0035774 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | 2.01e-04 | 1374 | 26 | 8 | GO:0006811 | |
| GeneOntologyBiologicalProcess | regulation of insulin secretion involved in cellular response to glucose stimulus | 2.07e-04 | 92 | 26 | 3 | GO:0061178 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic anion transport | 2.31e-04 | 18 | 26 | 2 | GO:0044070 | |
| GeneOntologyBiologicalProcess | insulin secretion involved in cellular response to glucose stimulus | 2.81e-04 | 102 | 26 | 3 | GO:0035773 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 3.51e-04 | 1115 | 26 | 7 | GO:0034220 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | 4.40e-04 | 1157 | 26 | 7 | GO:0006812 | |
| GeneOntologyBiologicalProcess | positive regulation of insulin secretion | 4.53e-04 | 120 | 26 | 3 | GO:0032024 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell membrane repolarization | 6.50e-04 | 30 | 26 | 2 | GO:0099623 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 8.37e-04 | 922 | 26 | 6 | GO:0098662 | |
| GeneOntologyBiologicalProcess | regulation of protein secretion | 9.07e-04 | 350 | 26 | 4 | GO:0050708 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 9.36e-04 | 942 | 26 | 6 | GO:0098655 | |
| GeneOntologyBiologicalProcess | positive regulation of peptide hormone secretion | 9.89e-04 | 157 | 26 | 3 | GO:0090277 | |
| GeneOntologyBiologicalProcess | positive regulation of peptide secretion | 1.06e-03 | 161 | 26 | 3 | GO:0002793 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell membrane repolarization | 1.22e-03 | 41 | 26 | 2 | GO:0099622 | |
| GeneOntologyBiologicalProcess | regulation of membrane repolarization | 1.22e-03 | 41 | 26 | 2 | GO:0060306 | |
| GeneOntologyBiologicalProcess | metal ion transport | 1.28e-03 | 1000 | 26 | 6 | GO:0030001 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 1.39e-03 | 1017 | 26 | 6 | GO:0098660 | |
| GeneOntologyCellularComponent | endosome membrane | 7.83e-05 | 602 | 26 | 6 | GO:0010008 | |
| GeneOntologyCellularComponent | early endosome membrane | 1.29e-04 | 212 | 26 | 4 | GO:0031901 | |
| GeneOntologyCellularComponent | neuron projection membrane | 1.42e-04 | 82 | 26 | 3 | GO:0032589 | |
| GeneOntologyCellularComponent | early endosome | 2.79e-04 | 481 | 26 | 5 | GO:0005769 | |
| GeneOntologyCellularComponent | synaptic membrane | 6.71e-04 | 583 | 26 | 5 | GO:0097060 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 7.91e-04 | 1293 | 26 | 7 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 8.13e-04 | 1299 | 26 | 7 | GO:0098827 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | 8.43e-04 | 1307 | 26 | 7 | GO:0030659 | |
| GeneOntologyCellularComponent | vesicle membrane | 9.15e-04 | 1325 | 26 | 7 | GO:0012506 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 9.23e-04 | 1327 | 26 | 7 | GO:0042175 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 9.52e-04 | 157 | 26 | 3 | GO:0098839 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.15e-03 | 378 | 26 | 4 | GO:0034702 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.93e-03 | 201 | 26 | 3 | GO:0099634 | |
| GeneOntologyCellularComponent | leading edge membrane | 2.19e-03 | 210 | 26 | 3 | GO:0031256 | |
| GeneOntologyCellularComponent | dendrite membrane | 2.20e-03 | 56 | 26 | 2 | GO:0032590 | |
| GeneOntologyCellularComponent | nuclear inner membrane | 2.44e-03 | 59 | 26 | 2 | GO:0005637 | |
| GeneOntologyCellularComponent | endosome | 2.62e-03 | 1167 | 26 | 6 | GO:0005768 | |
| GeneOntologyCellularComponent | apical plasma membrane | 2.90e-03 | 487 | 26 | 4 | GO:0016324 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 3.74e-03 | 523 | 26 | 4 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 4.47e-03 | 550 | 26 | 4 | GO:1990351 | |
| GeneOntologyCellularComponent | presynaptic membrane | 4.78e-03 | 277 | 26 | 3 | GO:0042734 | |
| GeneOntologyCellularComponent | main axon | 5.45e-03 | 89 | 26 | 2 | GO:0044304 | |
| GeneOntologyCellularComponent | apical part of cell | 5.80e-03 | 592 | 26 | 4 | GO:0045177 | |
| GeneOntologyCellularComponent | membrane protein complex | 8.89e-03 | 1498 | 26 | 6 | GO:0098796 | |
| Domain | Ion_trans_dom | 1.51e-05 | 114 | 25 | 4 | IPR005821 | |
| Domain | Ion_trans | 1.51e-05 | 114 | 25 | 4 | PF00520 | |
| Domain | PAS_9 | 7.69e-05 | 10 | 25 | 2 | PF13426 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 1.55e-04 | 14 | 25 | 2 | IPR003938 | |
| Domain | PAS_fold_3 | 4.28e-04 | 23 | 25 | 2 | IPR013655 | |
| Domain | PAS_3 | 4.28e-04 | 23 | 25 | 2 | PF08447 | |
| Domain | PAS-assoc_C | 4.66e-04 | 24 | 25 | 2 | IPR000700 | |
| Domain | PAC | 5.48e-04 | 26 | 25 | 2 | IPR001610 | |
| Domain | PAC | 5.48e-04 | 26 | 25 | 2 | SM00086 | |
| Domain | PAC | 5.48e-04 | 26 | 25 | 2 | PS50113 | |
| Domain | CNMP_BINDING_1 | 8.32e-04 | 32 | 25 | 2 | PS00888 | |
| Domain | CNMP_BINDING_2 | 8.32e-04 | 32 | 25 | 2 | PS00889 | |
| Domain | PAS | 8.32e-04 | 32 | 25 | 2 | SM00091 | |
| Domain | cNMP | 9.40e-04 | 34 | 25 | 2 | SM00100 | |
| Domain | PAS | 9.40e-04 | 34 | 25 | 2 | IPR000014 | |
| Domain | PAS | 9.40e-04 | 34 | 25 | 2 | PS50112 | |
| Domain | cNMP_binding | 9.40e-04 | 34 | 25 | 2 | PF00027 | |
| Domain | cNMP-bd_dom | 9.96e-04 | 35 | 25 | 2 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 9.96e-04 | 35 | 25 | 2 | PS50042 | |
| Domain | cNMP-bd-like | 1.17e-03 | 38 | 25 | 2 | IPR018490 | |
| Domain | - | 1.87e-03 | 48 | 25 | 2 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 2.11e-03 | 51 | 25 | 2 | IPR014710 | |
| Domain | ZINC_PROTEASE | 7.56e-03 | 98 | 25 | 2 | PS00142 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 27308891 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 23818989 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 36961815 | ||
| Pubmed | Bimodal regulation of an Elk subfamily K+ channel by phosphatidylinositol 4,5-bisphosphate. | 2.41e-05 | 10 | 26 | 2 | 26503718 | |
| Pubmed | 7.20e-05 | 985 | 26 | 6 | 12975309 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.52e-04 | 139 | 26 | 3 | 16985003 | |
| Pubmed | 2.78e-04 | 430 | 26 | 4 | 16303743 | ||
| Pubmed | Serum response factor mediates NGF-dependent target innervation by embryonic DRG sensory neurons. | 3.52e-04 | 37 | 26 | 2 | 18498735 | |
| Pubmed | 3.91e-04 | 39 | 26 | 2 | 23864651 | ||
| Pubmed | 4.12e-04 | 40 | 26 | 2 | 16382104 | ||
| Interaction | GSG1L interactions | 4.07e-06 | 3 | 24 | 2 | int:GSG1L | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 4.28e-03 | 172 | 26 | 2 | chr16p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 1.62e-02 | 345 | 26 | 2 | chr11q12 | |
| GeneFamily | Potassium voltage-gated channels | 7.14e-04 | 40 | 18 | 2 | 274 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Papillary_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.31e-06 | 141 | 26 | 4 | 330f944b38c3170dfc79ab033fae7b9ab71e840d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 4.11e-06 | 188 | 26 | 4 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | (7)_Epithelial-A_(AT2)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.75e-06 | 195 | 26 | 4 | c9a6c65ee18d83bf34a4713d306a6e30db1325c2 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-06 | 200 | 26 | 4 | 23088edc62bf7d4db890937bfd7925dc316fcc76 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Medullary_Carcinoma-4|TCGA-Breast / Sample_Type by Project: Shred V9 | 5.97e-05 | 131 | 26 | 3 | 1b467eefad0265cf6dba7831d4d597b8b8e69dd4 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D175|Adult / Lineage, Cell type, age group and donor | 8.93e-05 | 150 | 26 | 3 | b0b6ba3686d3eb8a9b249d30be14111de3b893be | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.84e-05 | 155 | 26 | 3 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | ILEUM-non-inflamed-(2)_B_cell-(2)_Naive_B_cells|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.14e-04 | 163 | 26 | 3 | 9add806d706f7170a49b2c2dcc14343e9befd26c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 166 | 26 | 3 | 739dfbe927f409821ff23aca6e47ebe78f57e859 | |
| ToppCell | Ionocyte-iono-1|World / Class top | 1.27e-04 | 169 | 26 | 3 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 169 | 26 | 3 | ccb7b2daa65cb5f4c1e7a48b3bcdf0cb8f7675c3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 169 | 26 | 3 | 716e9d4c5fb99c56b76afaa5ed90bfa859fde802 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 169 | 26 | 3 | 319cba07263bf41fcbcbfecd117f91b729394241 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.29e-04 | 170 | 26 | 3 | d682178d11d67eb5a02d0c6b3967645e37bcc62a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 170 | 26 | 3 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-04 | 170 | 26 | 3 | 84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 170 | 26 | 3 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | Ionocyte|World / Class top | 1.29e-04 | 170 | 26 | 3 | d2e592f2a679e6a8d32f2b752d9a3c493e50ced4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 170 | 26 | 3 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 171 | 26 | 3 | 5447b78148f7bccb727e2fc108589b2af02a5d31 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.32e-04 | 171 | 26 | 3 | 1af575809b3334bfaa019ff26c56e6cb03c82ee8 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 172 | 26 | 3 | a7eee0a30d2fe20c865a07b9004c6a821a72c0c4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 172 | 26 | 3 | cecfe5cf20f317ea01b4604789e07a14481c4cd6 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 172 | 26 | 3 | 0a9fe2cd28203970295a1288078c66eadac1c9ed | |
| ToppCell | Ionocyte-iono-2|World / Class top | 1.36e-04 | 173 | 26 | 3 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.36e-04 | 173 | 26 | 3 | e1de849dcd96063136bdac87e050ddbd55cabdcc | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 173 | 26 | 3 | 8335b77f730ed43fc348a005566e73a103c6774b | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.36e-04 | 173 | 26 | 3 | f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-04 | 173 | 26 | 3 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.38e-04 | 174 | 26 | 3 | 7e7b13de916cd4fa0fa6fb06e6b4942877afa9fb | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-04 | 174 | 26 | 3 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 175 | 26 | 3 | bfac175b79bb7d3d81074a2407c206a7647ee75d | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.41e-04 | 175 | 26 | 3 | 13b8f7dc38c90b74d4a20a84a8705d8e2ec244f6 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 175 | 26 | 3 | c94fb35bbac95123201ca87ca835aecaefc0c490 | |
| ToppCell | COVID-19-kidney-CD-IC-A|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.43e-04 | 176 | 26 | 3 | 45028197364c64e93e3ffe86aff773d47a477d49 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 178 | 26 | 3 | eafacc8cd3e986d6ca309e05b6e241331a584fa5 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 178 | 26 | 3 | 370749834a11d981e9ede26d5f63f0ecb551c015 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 178 | 26 | 3 | 6a5c31e976852edc7d9e899da8e2a1bf23d36759 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 178 | 26 | 3 | 731e1e8eff2c4018c75dfc66632a316010a09a9a | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 179 | 26 | 3 | 7329b45376a9e9a4fe34d4aa0b33af6dda0a8e3b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 179 | 26 | 3 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 179 | 26 | 3 | 6e4740f99f66d3e9348fa5057cf1030454819aa8 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-04 | 179 | 26 | 3 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 179 | 26 | 3 | ee60ac43fb62c09967a26bbcf9306ac5ea2bdc1e | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-04 | 180 | 26 | 3 | 78fdcfb3fdbf36469cae78407cda5bd0996930d8 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.56e-04 | 181 | 26 | 3 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Ionocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.58e-04 | 182 | 26 | 3 | 6e7dac78dc030f74e546b9f6db07556e9bb13ac2 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Ionocyte-Ionocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.58e-04 | 182 | 26 | 3 | cd972d30519db706477c6b0c901165b81b74abed | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.61e-04 | 183 | 26 | 3 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 184 | 26 | 3 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 184 | 26 | 3 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-04 | 184 | 26 | 3 | a60802e11dcc5f932811260b08a95a32f60f6b19 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 184 | 26 | 3 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 184 | 26 | 3 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.63e-04 | 184 | 26 | 3 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-04 | 184 | 26 | 3 | 39c230d32e4259bc784e0edfd9e2884c96898564 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-04 | 184 | 26 | 3 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-04 | 184 | 26 | 3 | 2a2fb691cc9414ef5b06c26239d2da03d6d7e5c2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 184 | 26 | 3 | 2a8338e94937686a148b5433515700ca0f674058 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 184 | 26 | 3 | a7399a72f065d68800e3e0b2031d9894e0cc0ba4 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 184 | 26 | 3 | f4344f3c407b2d4d703fe56e43d84dbfe60ba833 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.66e-04 | 185 | 26 | 3 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.69e-04 | 186 | 26 | 3 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.69e-04 | 186 | 26 | 3 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | facs-Lung-18m-Epithelial-alveolar_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.69e-04 | 186 | 26 | 3 | c7214e762b3b48197fdd0b36a50a4de2550a888f | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-04 | 186 | 26 | 3 | 0c477016c1b539b3086a8066c3c6443f08c222a3 | |
| ToppCell | facs-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-04 | 187 | 26 | 3 | a5318c888b334e8695f38971a7d100b93cdaf04b | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.71e-04 | 187 | 26 | 3 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.71e-04 | 187 | 26 | 3 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | facs-Lung-18m-Epithelial-alveolar_epithelial-type_II_pneumocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-04 | 187 | 26 | 3 | 64ba0df991eab8b2632751805d758c5f2711f4d7 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 26 | 3 | 8385fd384fc55e3b17802bb6698eb93b2c16d7f2 | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 1.74e-04 | 188 | 26 | 3 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | normal-na-Lymphocytic_B-B_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.74e-04 | 188 | 26 | 3 | ec72ba73b10c6f2ff39699b6b46b90a3e95a4c24 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 188 | 26 | 3 | cb9d0b48e2fd9cc576132803273b9c0382900944 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-04 | 189 | 26 | 3 | 6f2322d017b74a1757c81d6e06f50ead8c3dd0cc | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | 4dc32b463546bbe7250dddd281b92ad17ec22da1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 189 | 26 | 3 | 0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 1.77e-04 | 189 | 26 | 3 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-04 | 189 | 26 | 3 | 926b5fa3064b501a57ba78583e8af33532add455 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_naive|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.79e-04 | 190 | 26 | 3 | e63945fa1dcd58bee129f1dd0c23b64a76241554 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.79e-04 | 190 | 26 | 3 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_naive-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.79e-04 | 190 | 26 | 3 | fa65bc5a178ae0c80a9bd4b282e4539493128a64 | |
| ToppCell | 368C-Epithelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-04 | 190 | 26 | 3 | 459811e88d3001816c2d89034e0921c24918c17f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-04 | 190 | 26 | 3 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.82e-04 | 191 | 26 | 3 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.82e-04 | 191 | 26 | 3 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-04 | 191 | 26 | 3 | a8d77095ba20b47fc70ba04f80759fbce873253d | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.82e-04 | 191 | 26 | 3 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 192 | 26 | 3 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | B_cell_maturation-Naive_B_cell|World / Lineage and Cell class | 1.85e-04 | 192 | 26 | 3 | 58267a11c938a380c6e26f4e4ce63f3b4be79fdc | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.85e-04 | 192 | 26 | 3 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 192 | 26 | 3 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.88e-04 | 193 | 26 | 3 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.88e-04 | 193 | 26 | 3 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.88e-04 | 193 | 26 | 3 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-erythroid-mid_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.88e-04 | 193 | 26 | 3 | 1e19f80c52833fb21a8d597a3ba2c4ff464c4559 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-04 | 194 | 26 | 3 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.91e-04 | 194 | 26 | 3 | 3043f6230fa723037c8cf7123f611ae847b39fd4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-04 | 194 | 26 | 3 | abce1e824ce2512741c313a5ec336d12f580b093 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-04 | 194 | 26 | 3 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| Computational | Genes in the cancer module 458. | 2.21e-05 | 38 | 16 | 3 | MODULE_458 | |
| Drug | retinoic acid; Down 200; 1uM; HL60; HG-U133A | 2.07e-06 | 196 | 25 | 5 | 390_DN | |
| Drug | pimozide | 1.07e-05 | 127 | 25 | 4 | CID000016362 | |
| Drug | W-A-Y | 3.12e-05 | 56 | 25 | 3 | CID000004368 | |
| Drug | IAA-94 | 4.04e-05 | 61 | 25 | 3 | CID000003667 | |
| Drug | WAY-123,398 | 5.18e-05 | 10 | 25 | 2 | CID000132160 | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A | 5.73e-05 | 195 | 25 | 4 | 4369_DN | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 5.85e-05 | 196 | 25 | 4 | 6786_DN | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; HL60; HT_HG-U133A | 6.08e-05 | 198 | 25 | 4 | 2724_DN | |
| Drug | Vigabatrin [60643-86-9]; Up 200; 31uM; MCF7; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 5415_UP | |
| Drug | clofilium | 7.20e-05 | 74 | 25 | 3 | CID000002798 | |
| Drug | N-(p-amylcinnamoyl)anthranilic acid | 1.04e-04 | 14 | 25 | 2 | CID000001974 | |
| Drug | verapamil | 1.68e-04 | 490 | 25 | 5 | CID000002520 | |
| Drug | MK-499 | 1.96e-04 | 19 | 25 | 2 | CID000127718 | |
| Drug | Hdba | 1.96e-04 | 19 | 25 | 2 | CID000003896 | |
| Drug | pyraclofos | 2.09e-04 | 106 | 25 | 3 | CID000093460 | |
| Drug | diquafosol | 2.17e-04 | 20 | 25 | 2 | CID000148196 | |
| Drug | Phosphatidylinositol 4,5-Diphosphate | 2.40e-04 | 21 | 25 | 2 | ctd:D019269 | |
| Drug | ether-a | 2.64e-04 | 22 | 25 | 2 | CID000501025 | |
| Drug | panorama | 2.64e-04 | 22 | 25 | 2 | CID000008174 | |
| Drug | pentanol | 2.89e-04 | 23 | 25 | 2 | CID000006276 | |
| Drug | homophenylalanine | 4.94e-04 | 30 | 25 | 2 | CID000102530 | |
| Drug | Bay K 8644 | 5.80e-04 | 150 | 25 | 3 | CID000002303 | |
| Drug | CNS 1145 | 5.99e-04 | 33 | 25 | 2 | CID000190902 | |
| Drug | IHC-64 | 5.99e-04 | 33 | 25 | 2 | CID000162753 | |
| Drug | XE991 | 5.99e-04 | 33 | 25 | 2 | CID000656732 | |
| Drug | procaine | 6.14e-04 | 153 | 25 | 3 | CID000004914 | |
| Drug | Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; HL60; HG-U133A | 7.92e-04 | 167 | 25 | 3 | 1607_UP | |
| Drug | carbachol | 7.98e-04 | 688 | 25 | 5 | CID000002551 | |
| Drug | felodipine | 8.19e-04 | 169 | 25 | 3 | CID000003333 | |
| Drug | lavendustin A | 8.48e-04 | 171 | 25 | 3 | CID000003894 | |
| Drug | Isoflupredone acetate [338-98-7]; Up 200; 9.6uM; HL60; HT_HG-U133A | 8.92e-04 | 174 | 25 | 3 | 1873_UP | |
| Drug | papaverine | 9.22e-04 | 176 | 25 | 3 | CID000004680 | |
| Drug | mM Q | 9.25e-04 | 41 | 25 | 2 | CID000445446 | |
| Drug | AC1MRHRO | 1.02e-03 | 43 | 25 | 2 | CID003468412 | |
| Drug | linopirdine | 1.02e-03 | 43 | 25 | 2 | CID000003932 | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; HL60; HT_HG-U133A | 1.06e-03 | 185 | 25 | 3 | 2142_UP | |
| Drug | hydroxyisocaproate | 1.06e-03 | 44 | 25 | 2 | CID000083697 | |
| Disease | Distal arthrogryposis | 2.47e-05 | 9 | 25 | 2 | cv:C0265213 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RYITVHKSLIFVLIW | 851 | P13569 | |
| WLSVVSEVLYILLLV | 136 | Q6UXU4 | |
| LTIALFTIYVLWTLV | 181 | Q9P0N8 | |
| VVILIVVYHVYWLEM | 371 | Q9NPH3 | |
| DWLILLLVIYTAIFT | 411 | Q9NS40 | |
| LLLASVVWFILVHVT | 46 | Q96BI3 | |
| DWIILILTFYTAILV | 221 | O95259 | |
| VLHNYLVWRVVVVLS | 396 | O95672 | |
| QILILEVLAWLIVYH | 176 | A8MWK0 | |
| FTVILIWISVLAYVL | 141 | Q9UJ42 | |
| TLLYVVHAVFSLIRW | 136 | P21145 | |
| FLLHTTWFVILSVVL | 26 | Q9Y4D2 | |
| IVATALWVLIAYILY | 641 | Q68CP4 | |
| WLFTLVVSLVLVTIY | 201 | O75844 | |
| YWLVIVLVFLNTLTI | 526 | Q01668 | |
| WIVFLLLIVFYTAIT | 196 | Q15391 | |
| VLEWIIYTTGIIFVL | 806 | O75762 | |
| ITYIVLLVLHTVWNG | 341 | P18577 | |
| LTLVYFSILWTLTHI | 746 | Q9UJ98 | |
| WILELHIIKIVSSYI | 936 | Q9H5I5 | |
| HIIKIVSSYIIWVSV | 941 | Q9H5I5 | |
| ITVITIDWISRHLYF | 1226 | P08922 | |
| LTLIVLIITYLYWQI | 911 | Q6UXY8 | |
| SIKYFIEWIIILILH | 1206 | Q13395 | |
| VLVTSLRYHLFIWSV | 936 | Q5H8A4 | |
| YWLTFVHVIITLLVI | 406 | Q6PJF5 | |
| LTLVHFVVTWLGLYI | 46 | Q7Z769 |